To Assess Safety, Tolerability and PK of NEX-20A, a Subcutaneous Prolonged-release Injection to Healthy Subjects
Nanexa AB
Nanexa AB
H. Lee Moffitt Cancer Center and Research Institute
Northwestern University
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Abramson Cancer Center at Penn Medicine
Dana-Farber Cancer Institute
Washington University School of Medicine
Washington University School of Medicine